Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Cash from Financing Activities (2019 - 2025)

Addex Therapeutics' Cash from Financing Activities history spans 7 years, with the latest figure at -$118.4 billion for Q2 2025.

  • On a quarterly basis, Cash from Financing Activities rose 34.95% to -$118.4 billion in Q2 2025 year-over-year; TTM through Jun 2025 was -$8.0 billion, a 99.87% increase, with the full-year FY2025 number at $1.4 million, up 1092.23% from a year prior.
  • Cash from Financing Activities came in at -$118.4 billion for Q2 2025, down from $109.0 billion in the prior quarter.
  • The five-year high for Cash from Financing Activities was $6130.2 billion in Q2 2023, with the low at -$6000.8 billion in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$4.8 billion across 5 years, with a median of -$136767.6 in 2022.
  • Peak annual rise in Cash from Financing Activities hit 3467832720.52% in 2023, while the deepest fall reached 3422757924.1% in 2023.
  • Year by year, Cash from Financing Activities stood at $8.8 million in 2021, then crashed by 101.98% to -$175321.9 in 2022, then tumbled by 3422757924.1% to -$6000.8 billion in 2023, then skyrocketed by 97.97% to -$121.7 billion in 2024, then grew by 2.77% to -$118.4 billion in 2025.
  • Business Quant data shows Cash from Financing Activities for ADXN at -$118.4 billion in Q2 2025, $109.0 billion in Q1 2025, and -$121.7 billion in Q4 2024.